Endometrial cancer is the most common gynecologic malignancy in developed countries,
with increasing incidence and mortality rates worldwide. While most cases are successfully …

Five to 10% of patients with stage IA, grade 1 or 2, endometrioid adenocarcinoma
subsequently develop locoregional or distant recurrence. These patients have significantly …

Objectives To develop a fusion model based on clinicopathological factors and MRI
radiomics features for the prediction of recurrence risk in patients with endometrial cancer …

Background The preoperative peripheral blood neutrophil-lymphocyte ratio (NLR), platelet-
lymphocyte ratio (PLR) and monocyte-lymphocyte ratio (MLR) have been reported to be …

The role of β‐catenin/TCF transcriptional activity in endometrial cancer (EC) recurrence is
not well understood. We assessed the impact of Wnt/β‐catenin inhibition in EC models. In an …

Background: The majority of patients diagnosed with early stage endometrial cancer have a
favorable prognosis; however, approximately 10% to 15% experience a recurrence …

Objective The purpose of this study was to find a cut-off value of the immunohistochemical
parameter Ki67 for stage I–II endometrial cancer. Materials and Methods The …

Recurrence is the main cause of death in patients with endometrial cancer (EC). This study
aimed to construct and validate a nomogram to predict the recurrence-free survival of …

Background Endometrial cancer stem-like cells (ECSCs) have been proven to be
responsible for recurrence, metastasis, and drug-resistance in patients with endometrial …

Objective Endometrial cancer recurrence is one of the main factors leading to increased
mortality, and there is a lack of predictive models. Our study aimed to establish a nomogram …